|
 If you have not been paying close attention, you might still think that you need to be enrolled in the Apple Developer Program for $99 per year to install iOS developer betas, but that has not been the case for a few years now. In fact, anyone can install the iOS 27 developer beta on their iPhone for free, and the process is quite easy.
|
|
 Microsoft engineers have published benchmark results showing that a Chromium-based browser using its own rendering engine scores 28.6% higher than Safari on Apple's own Speedometer 3.1 performance test on iOS.
|
|
The White House app will be automatically loaded onto DHS staff's work phones, Politico said.
|
|
Jackery's new ultra-thin FridgeGuard joins a growing market of portable power stations designed to keep your appliances powered. I tried it.
|
|
Anthropic is pushing back on US restrictions on Fable 5 and Mythos 5 as cybersecurity experts warn the move could hurt defenders and AI access.
|
|
NEW RESOURCES Nature: ‘Every box has been opened': London botanic gardens digitizes 7 million specimens. "The Royal Botanic Gardens at Kew in southwest London announced on 16 June that it has completed […]
|
|
 Nimble this week debuted the SharePower, a USB-C power bank that can be used as a single charger or split into two chargers so it can be shared with a friend.
|
|
NEW RESOURCES Daily Bruin: UCLA historians preserve documents, photos in ‘Power from the Past' online archive. "UCLA historians launched a revamped digital labor history archive in April, preserving materials from movements led […]
|
RELATED ARTICLES | | |
|
Law firms and corporate legal teams using Google Workspace can now access Litera's battle-tested document comparison with AI
|
|
 An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERSA UN-backed agency has struck a deal with nearly 30 generic drugmakers to make low-cost versions of Merck's COVID-19 pill molnupiravir for poorer countries, expanding access to a drug seen as a weapon to fight the pandemic.
The antiviral drug, which received emergency use
|
|
